Institutional Ownership
Tuhura Biosciences Inc
CUSIP 898920103COMHURAQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
26.7%
Max % of class reported
Institutional Holders
84
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Highbridge Capital Management, LLC | 13G | 9.1% | 6.06M | SEC |
| 2 | Oct 31, 2025 | The Vanguard Group | 13G/A | 4.4% | 2.27M | SEC |
| 3 | Aug 14, 2025 | Kp Biotech Group LLC | 13G/A | 0.9% | 1.22T | SEC |
| 4 | Aug 14, 2025 | Ca Patel F&Amp;F Investments, LLC | 13G/A | 0.9% | 1.22T | SEC |
| 5 | Jul 29, 2025 | The Vanguard Group | 13G | 5.1% | 2.23M | SEC |
| 6 | Oct 25, 2024 | Theofilos Charles Steve | 13G | 5.9% | 2.51M | SEC |
| 7 | Oct 25, 2024 | Patel Samir Rashmikant | 13G | 5.8% | 2.47M | SEC |
| 8 | Oct 25, 2024 | Kp Biotech Group LLC | 13G | 6.1% | 2.57M | SEC |
| 9 | Oct 25, 2024 | Ca Patel F&F Investments, LLC | 13G | 6.1% | 2.57M | SEC |
| 10 | Oct 25, 2024 | Patel Vijay | 13D | 26.7% | 12.35M | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tuhura Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 2.45M | $4.39M |
| 2 | Geode Capital Management, LLC | 986.9K | $1.77M |
| 3 | Aqr Capital Management LLC | 607.2K | $1.09M |
| 4 | State Street Corp | 512.9K | $918.1K |
| 5 | Northern Trust Corp | 298.2K | $533.8K |
| 6 | Bank Of New York Mellon Corp | 211.6K | $378.7K |
| 7 | Apollon Wealth Management, LLC | 158.0K | $282.8K |
| 8 | Cetera Investment Advisers | 140.2K | $251.0K |
| 9 | Suncoast Equity Management | 104.4K | $186.9K |
| 10 | Charles Schwab Investment Management Inc | 98.9K | $177.1K |